Clinical Trial Update: A Study of HLD-0117 in Patients With Metastatic Breast Cancer [Phase 1]

View source ↗

Summary

This clinical trial update indicates that a Phase 1 study of HLD-0117 for metastatic breast cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• HLD-0117

Snippet

Sponsor: Halda Therapeutics OpCo, Inc. | Conditions: Metastatic Breast Cancer | Phase 1 | Status: RECRUITING